Status:
TERMINATED
Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease
Lead Sponsor:
NHS Greater Glasgow and Clyde
Conditions:
Heart Failure
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
The principal research objectives are to demonstrate cardioselective beta-blockade using bisoprolol is not inferior to placebo with regard to pulmonary function and improves quality of life in patient...
Eligibility Criteria
Inclusion
- symptomatic NYHA II or III chronic heart failure
- left ventricular systolic dysfunction
- moderate or severe chronic obstructive pulmonary disease
- with or without significant reversibility
Exclusion
- beta-blocker contraindications
- non-dihydropyridine (diltiazem / verapamil) calcium channel blockers
- recent coronary percutaneous intervention or coronary artery bypass graft surgery
- haemodynamically significant valvular disease or hypertrophic cardiomyopathy.
- active myocarditis or pericarditis.
- recent cerebrovascular accident or transient ischaemic attack
- serious concurrent systemic disease, such as malignancy, resulting in likely reduced life expectancy
- pregnancy, childbearing potential with inadequate contraception, breast feeding
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00702156
Start Date
March 1 2005
End Date
July 1 2008
Last Update
September 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiopulmonary Transplant Unit Glasgow Royal Infirmary
Glasgow, Scotland, United Kingdom, G31 2ER